Testbed 2: T cell immunotherapies to cure cancer

Engineered T Cells:  T cells from patient or healthy donors can be re-programmed to recognize, attack, and destroy resistant cancer cells

Goal: Integrate technologies and processes developed by the Thrusts to expand CD19 CAR-T cells to specifically sense and eliminate B cells, and re-program CAR-T cells  to target unresponsive breast tumors.